Green Thumb Industries Inc. (OTCMKTS:GTBIF - Free Report) - Investment analysts at Roth Capital lowered their Q2 2025 EPS estimates for Green Thumb Industries in a note issued to investors on Thursday, May 8th. Roth Capital analyst W. Kirk now expects that the company will earn $0.05 per share for the quarter, down from their prior forecast of $0.07. The consensus estimate for Green Thumb Industries' current full-year earnings is $0.32 per share. Roth Capital also issued estimates for Green Thumb Industries' Q3 2025 earnings at $0.05 EPS, Q4 2025 earnings at $0.06 EPS, FY2025 earnings at $0.19 EPS, Q1 2026 earnings at $0.06 EPS, Q2 2026 earnings at $0.07 EPS, Q3 2026 earnings at $0.07 EPS and Q4 2026 earnings at $0.08 EPS.
Green Thumb Industries Stock Up 0.1%
GTBIF stock traded up $0.01 during mid-day trading on Monday, hitting $5.54. 256,874 shares of the company were exchanged, compared to its average volume of 459,636. The firm has a market capitalization of $1.17 billion, a P/E ratio of 23.08 and a beta of 1.32. The business has a fifty day simple moving average of $5.77 and a 200-day simple moving average of $7.26. Green Thumb Industries has a 12-month low of $4.63 and a 12-month high of $14.30.
Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.01). Green Thumb Industries had a return on equity of 3.39% and a net margin of 5.38%. The firm had revenue of $279.54 million for the quarter, compared to analyst estimates of $283.36 million.
About Green Thumb Industries
(
Get Free Report)
Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.
Further Reading

Before you consider Green Thumb Industries, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Green Thumb Industries wasn't on the list.
While Green Thumb Industries currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.